Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Lettország
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisFelfüggesztveEfficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
- Where
- Riga
- Életkor
- 18 év to 80 év
- People
- 412 worldwide
- Run by
- AB Science
See details and how to joinNCT07174492 · EU 2024-511244-12-01 - 1. fázisNot yet taking people in LettországA PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS
- Where
- Riga
- Életkor
- 18 év and over
- People
- 16
- Run by
- Tranquis Therapeutics Inc.
See details and how to join2023-504746-54-00